Core Viewpoint - China Smart Health (00348) expects to achieve a profit attributable to shareholders ranging from approximately HKD 100,000 to HKD 2 million for the six months ending June 30, 2025, a significant turnaround from a loss of approximately HKD 29 million for the same period ending June 30, 2024 [1] Financial Performance - The expected profit turnaround is primarily due to the reversal of impairment losses on receivables, with an expected recovery of approximately HKD 3 million in the first half of 2025 compared to an impairment loss of approximately HKD 6 million in the first half of 2024 [1] - General and administrative expenses are projected to decrease from approximately HKD 18 million in the first half of 2024 to approximately HKD 8 million in the first half of 2025, attributed to effective cost-saving measures implemented by the company [1] - Unrealized fair value gains on financial assets measured at fair value through profit or loss are expected to be approximately HKD 12 million in the first half of 2025, contrasting with an unrealized fair value loss of approximately HKD 5 million in the first half of 2024 [1]
中国智能健康(00348)发盈喜 预计中期股东应占溢利约10万至200万港元